Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             14 results found
no title author magazine year volume issue page(s) type
1 ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial ☆ Audinot, B.

35 6 p. 559-568
article
2 Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET ☆ Gennari, A.

35 6 p. 549-558
article
3 Editorial Board
35 6 p. iii
article
4 ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma Powles, T.

35 6 p. 485-490
article
5 Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer Laskar, R.S.

35 6 p. 523-536
article
6 Identifying genetic loci associated with an increased risk for early-onset colorectal cancer Kelsen, D.

35 6 p. 483-484
article
7 Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 ☆ Melero, I.

35 6 p. 537-548
article
8 Oncogenic extrachromosomal DNA identification using whole-genome sequencing from formalin-fixed glioblastomas Noorani, I.

35 6 p. 570-573
article
9 Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ Ferreri, A.J.M.

35 6 p. 491-507
article
10 Reporting and analysis of immunotherapy trials adverse events: what is going wrong, how to do better? Pourmir, I.

35 6 p. 569-570
article
11 Table of Contents
35 6 p. i-ii
article
12 Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities Wang, X.

35 6 p. 508-522
article
13 VP3-2024: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse Le Cesne, A.

35 6 p. 576-577
article
14 VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial Li, H.

35 6 p. 574-575
article
                             14 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands